healthcare

  • Retrieve Medical, Partnering with ID.me, Enhances Security and Simplifies Access to Patient Health Records via Health Information Exchanges

    Retrieve Medical Holdings, Inc. is launching Retrieve Personal, a platform providing secure, immediate access to comprehensive medical records for patients and providers. Integrating with Health Information Exchanges (HIEs) and leveraging AI, Retrieve Personal compiles complete patient histories into actionable summaries. ID.me provides secure identity verification. This initiative addresses fragmented patient information but faces challenges like HIE interoperability and data standardization. The aim is portable health summaries, enhancing personalized healthcare and improving efficiency.

    2025年9月18日
  • REGENXBIO to Present at Upcoming Investor Conferences

    REGENXBIO (Nasdaq: RGNX) will participate in several investor conferences in September 2025, including events hosted by Wells Fargo, Morgan Stanley, Baird, and H.C. Wainwright. The company will engage in one-on-one meetings and fireside chats to discuss its strategic vision, clinical progress, and the potential of its AAV gene therapies for rare and retinal diseases, including RGX-202 for Duchenne muscular dystrophy and surabgene lomparvovec (ABBV-RGX-314) for wet AMD and diabetic retinopathy. Webcasts will be available on REGENXBIO’s website.

    2025年8月28日
  • OpenAI Unveils GPT-5, Available to All: More Human-Like Expertise

    OpenAI has launched GPT-5, touted as a significant upgrade with expert-level performance in programming, mathematics, writing, healthcare, and visual perception. GPT-5 features an intelligent model, a deep reasoning engine, and a real-time router. Free and paid users will get access, with subscribers enjoying higher usage. GPT-5 demonstrates improvements in response time, accuracy, instruction following, and reduced hallucination. It excels in programming, creative writing, and healthcare. GPT-5 Pro surpasses o3-Pro for complex tasks, achieving state-of-the-art results in GPQA.

    2025年8月7日
  • Weave to Announce Second Quarter 2025 Financial Results and Host Conference Call

    Weave (NYSE: WEAV) will release its Q2 2025 financial results on July 31, 2025, after market close. A conference call and webcast will follow at 4:30 p.m. ET, accessible via phone at (412) 902-1020 or (877) 502-7186, and online at investors.getweave.com. Weave provides SaaS solutions focusing on customer experience and payment processing for healthcare practices, aiming to streamline patient interactions and billing.

    2025年7月17日
  • Baxter Declares Quarterly Dividend

    Baxter International Inc. (BAX) declared a quarterly cash dividend of $0.17 per share, payable on October 1, 2025, to stockholders of record as of August 29, 2025. This establishes an indicated annual dividend rate of $0.68 per share. Baxter, a global medtech leader, provides a wide array of healthcare solutions. The release also contains cautionary statements regarding forward-looking financial projections and potential deviations in dividend payouts.

    2025年7月14日
  • Luo Yonghao’s New AI Product to Debut in Three Months; DeepSeek Founder Advises Him to “Make a Living Talking”

    Please provide the content you would like me to summarize. I need the text to create a concise English abstract for it.

    2025年6月21日
  • MEDIROM Healthcare Technologies Inc. Back in Compliance with NASDAQ Listing Standards

    MEDIROM Healthcare Technologies Inc. (MRM) has regained compliance with Nasdaq’s minimum bid price requirement. After receiving a notice of non-compliance on February 27, 2025, MEDIROM’s ADSs closed above $1.00 for ten consecutive business days, satisfying the exchange’s mandate. This positive development, announced June 5, 2025, signifies the company’s commitment to regulations and follows a period of uncertainty. MEDIROM operates over 300 wellness salons in Japan and offers health-tech solutions.

    2025年6月5日
  • Cyber Doc: Avoiding Overtreatment

    The article explores the potential and pitfalls of AI in healthcare. While AI doctors promise improved precision, studies reveal they can amplify existing biases in treatment based on factors like income, gender, or race. Concerns about data quality and inherent biases within healthcare systems necessitate adjustments. The solution involves a shift from a disease-centered approach to a focus on the overall patient, alongside ongoing medical progress and the use of data.

    2025年6月3日
  • Ant Group’s AI Health Assistant Passes Trustworthiness Assessment, Benefits 40 Million Users

    Ant Group’s “AI Health Guardian” has passed CAICT’s trustworthiness evaluation for large-scale medical health models, confirming its reliability. Launched in September 2024, the AI-powered service provides doctor recommendations, health assessments, and more. It leverages a medical-focused language model and has already served 40 million users, demonstrating successful integration and collaboration within healthcare.

    2025年6月3日